• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1999 Fiscal Year Final Research Report Summary

Molecular mechanism of spontaneous regression of neuroblastoma and its application to the therapy

Research Project

Project/Area Number 10470044
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field Pathological medical chemistry
Research InstitutionChiba Cancer Center Research Institute

Principal Investigator

NAKAGAWA Akira  Chiba Cancer Center Research Institute, Department of Biochemistry, Head, 研究局・生化学研究部, 部長 (50117181)

Co-Investigator(Kenkyū-buntansha) NAKAMURA Yuko  Chiba Cancer Center Research Institute, Department of Biochemistry, Research Fellow, 研究局・生化学研究部, 研究員 (60260254)
KAGEYAMA Hajume  Chiba Cancer Center Research Institute, Department of Biochemistry, Research Fellow, 研究局・生化学研究部, 研究員 (50260253)
OZAKI Toshinori  Chiba Cancer Center Research Institute, Department of Biochemistry, Senior Investigator, 研究局・生化学研究部, 研究員 (40260252)
ISOGAI Eriko  Chiba Cancer Center Research Institute, Department of Biochemistry, Research Fellow, 研究局・生化学研究部, 研究員 (40300917)
Project Period (FY) 1998 – 1999
KeywordsNeuroblastoma / regression / apoptosis / TrkA / MYCN / GDNF / Survivin / p73
Research Abstract

Translational research of the Primary neuroblastomas.
During the last 3 years, 600 samples of primary neuroblastoma have been sent to our laboratory and subjected to analysis of DNA ploidy, MYCN amplification, TrkA expression, 1p36 loss of heterozygosity. The results showed that a subset of neuroblastoma with a tendency to spontaneously regress had aneuploidy, single copy of MYCN, high levels of expression of TrkA and no loss of heterozygosity of 1p36. Especially, TrkA expression seemed to be one of the most important prognostic factors of neuroblastoma.
Molecular analysis of neuronal cell death in neuroblastoma cell lines.
The molecular mechanism of neuronal cell death which was induced by retinoic acid and was recued by the GDNF/Ret signaling was studied by using neuroblastoma cell line, CHP134. The results obtained were as follows. 1) Among the caspase family, only caspases-1, 3 and 9 were induced at both mRNA and protein levels. Only survivin among the IAP family molecules was induced … More . 2) In the p53 pathway, p21WAF1 was transiently induced, while other target genes such as Bax, PIG3 and Mdm2 were not. 3) Mitochondrial membrane potential was descreased. 4) The cell death was inhibited by activation of GDNF/NTN signaling. Thus, the retinoic acid-induced neuronal cell death appeared to be mediated by the activation of mitochondria 【thermodynamics】 caspases-9 and 3 pathway.
Functional role of survivin
Our previous study has suggested that survivin mapped to 17q25 is one of the candidate genes of the 17q gain which is often observed in advanced stages neuroblastomas. We found a novel splice variant, survivin-b, with insertion within the functional BIR domain. It was thought to be a loss of function variant. Survivin-a and b competed to bind the microtubule in vitro, suggesting that both isoforms might regulate life and death of neuroblastoma cells.
Functional analysis of p73
Based on the kockout mice, p73 may function during embryonic development and regulate neuronal cell death. We found that COOH-terminal region of p73 regulated negatively the transactivation function of NH2-terminal region and positively the induction of apoptosis Less

  • Research Products

    (40 results)

All Other

All Publications (40 results)

  • [Publications] Hishiki, T., Nakagawara, A., et al.: "Glial cell line derived neurotrophic factor/neurturin-induced differentiation and its enhncement by retinoic acid in primary human neuroblastomas expressing c-Ret, GFR α-1 and GFR α-2"Cancer Res.. 58. 2158-2165 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Hiwase, T., Nakagawara, A., et al.: "Enhancement of chemosensitivity towards anticancer drugs by high expression of caspase-1 in NIH3T3 cells"Anti-cancer Drugs. 9. 82-87 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Nishino, S., Nakagawara, A., et al.: "Immunohistochemical expression of tyrosine kinase(Trk) receptor proteins in mature neuronal cell tumors of the central nervous system"Clin. Neuropathol.. 17. 123-130 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Nakagawara, A: "The NGF Story and Neuroblastoma"Med. Pediatr. Oncol.. 31. 113-115 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Emonoto, H., Nakagawara, A., et al.: "In vivo Karyotypic evolution with altered biologycal characteristics in a case of neuroblastoma"J. Pediatr. Surg.. 33. 1404-1407 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Osada, M., Nakagawara, A., et al.: "Cloning and functinal analysis of human p51, structurally and functinonally resembling p53"Nat. Med.. 4. 839-843 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Nakagawara, A.: "Molecular basis of spontaneous regression of neuroblastoma : Role of nuerotrophic signals and genetic abnormalities"Human Cell. 11. 115-124 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kaneko, Y., Nakagawara, A., et al.: "Disomy 1 with terminal 1p deletion was frequent in mass screening-negative/late presenting neuroblastmas in young children, but not in mass screening-positive neuroblastomas in infants."Int. J. Cancer. 80. 54-59 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Ichimiya, S., Nakagawara, A., et al.: "p73 at chromosome 1p36.3 is lost in advanced stage neuroblastoma but its mutation is infrequent"Oncogene. 18. 1061-1066 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Takada, N., Nakagawara, A., et al.: "Indentification of a transactivation activity in the carboxy-terminal region of p73 which is impaired in the naturally occurring mutants found in human neuroblastomas"Cancer Res.. 59. 2810-2814 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Ozaki, T., Nakagawara, A., et al.: "Deletion of the COOOH-terminal region of p73 α enhances both its transactivation function and DNA-binding activity but inhibits induction of apoptosis in mammlian cells"Cancer Res.. 59. 5902-5907 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Sunahara, M., Nakagawara, A., et al.: "Mutational analysis of p51A/TAp63γ, a p53 homolog, in non-small cell lung cancer and breast cancer"Oncogene. 18. 3761-3765 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kato, S., Nakagawara, A et al.: "Transcriptional zctivities of p51/p63 missense mutations on the p53-downstream gene promoters"Cancer Res.. 59. 5908-5911 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Ikawa, S., Nakagawara, A., et al.: "p53 family genes : structural comparison, expression and mutation"Cell Death Differ.. 6. 1151-1161 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Han, S., Nakagawara, A., et al.: "Infrequent somatic mutation of the p73 gene in various human cancers"Eur. J. Surg. Oncol.. 25. 194-198 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Yang, H-W., Nakagawara, A., et al.: "Development of a polyclonal antibody with defined specificity against synthetic peptides from the N-myc oncoprotein, using multiple antigen peptide and hemocyanin conjugation methods"J. Pediatr. Surg.. 34. 454-460 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Nishio, s., Nakagawara, A., et al.: "Thoracic paravertebral genglioneuroma with high immunohistochemical expression of TrkA"Neuropathol.. 19. 51-56 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Hirai, M., Nakagawara, A., et al.: "1q23 gain is associated with progressive neuroblastoma resistant to aggressive treatment"Genes chromosomes Cancer. 25. 261-269 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Sugimoto, N., Nakagawara, A., et al.: "The human caspase-activated Dnase (CAD) gene : genomic structure, exonic single-nucleotide polymorphisms, and a highly polymorphic dinucleotide repeat at the CAD locus."J. Hum. Genet.. 44. 408-411 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Islam, A, Nakagawara, A., et al.: "High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma"Oncogene. 19. 617-623 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Hishiki, T.,Nakagawa, A., et al.: "Glial cell line-derived neurotrophic factor/neurturin-induced differentiation and its enhancement by retinoic acid in primary human neuroblastomas expressing c-Ret, GFRα-1 and GFRα-2."Cancer Res.. 58. 2158-2165 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Hiwasa, T.,Nakagawara, A., et al.: "Enhancement of chemosensitivity towards anticancer drugs by high expression of caspase-1 in NIH3T3 cells."Anti-cancer Drugs. 9. 82-87 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Nishio, S., Nakagawara, A., et al.: "Immunohistochemical expression of tyrosine kinase (Trk) receptor proteins in mature neuronal cell tumors of the central nervous system."Clin. Neuropathol.. 17. 123-130 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Nakagawara, A.: "The NGF Story and Neuroblastoma."Med. Pediatr. Oncol.. 31. 115-1998 (113)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Enomoto, H., Nakagawara, A., et at.: "In vivo karyotypic evolustion with altered biological characteristics in a case of neuroblastoma."J. Pediatr. Surg.. 33. 1404-1407 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Osada, M., Nakagawara, A., et al.: "Cloning and functional analysis of human p51, structurally and functionally resembling p53."Nat. Med.. 4. 839-843 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Nakagawara, A.: "Molecular basis of spontaneous regression of neuroblastoma Role of neurotrophic signals and genetic abnormalities."Human Cell. 11. 115-124 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kaneko, Y., Nakagawara, A., et al.: "Disomy 1 with terminal 1p deletion was frequent in mass screening-negative/late presenting neuroblastomas in young children, but not in mass screening-positive neuroblastomas in infants."Int. J. Cancer. 80. 54-59 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ichimiya, S., Nakagawara, A., et al.: "p73 at chromosome 1p36.3 is lost in advanced stage neuroblastoma but its mutation is infrequent."Oncogene. 18. 1061-6066 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Takada,N.,Nakagawara, A., et al.: "Identification of a transactivation activity in the carboxy-terminal region of p73 which is impaired in the naturally occurring mutants found in human neuroblastomas."Cancer Res.. 59. 2810-2814 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ozaki, T.,Nakagawara, A., et al.: "Deletion of the COOH-terminal region of p73α enhances both its transactivation function and DNA-binding activity but inhibits induction of apoptosis in mammalian cells."Cancer Res. 59. 5902-5907 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Sunahara, M., Nakagawara, A., et al.: "Mutational analysis of p51A/TAq63γ, a p53 homolog, in non-small cell lung cancer and breast cancer."Oncogene. 18. 3761-3765 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kato,S., Nakagawara, A., et al.: "Transcriptional activities of p51/p63 missense mutations on the p53-downstream gene promoters."Cancer Res.. 59. 5908-5911 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ikawa, S., Nakagawara, A., et al.: "p53 family genes: structural comparison, expression and mutation."Cell Death Differ.. 6. 1151-1161 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Han, S., Nakagawara, A., et al.: "Infrequent somatic mutations of the p73 gene in various human cancers."Eur. J. Surg. Oncol.. 25. 194-148 (1000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Yang, H-W., Nakagawara, A., et al.: "Development of a polyclonal antibody with defined specificity against synthetic peptides from the N-myc oncoprotein, using multiple antigen peptide and hemocyanin conjugation methods."J. Pediatr. Surg.. 34. 454-460 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Nishio, S., Nakagawara, A., et al.: "Thoracic paravertebral genglioneuroma with high immunohistochemical expression of TrkA."Neuropathol.. 19. 51-56 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Hirai, M., Nakagawara, A., et al.: "1q23 gain is associated with progressive neuroblastoma resistant to aggressive treatment."Genes Chromosomes Cancer. 25. 261-269 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Sugimoto,N., Nakagawara, A., et al.: "The human caspase-activated DNase (CAD) gene: genomic structure, exonic single-nucleotide polymorphisms, and a highly polymorphic dinucleotide repeat at the CAD locus."J. Hum. Genet.. 44. 408-411 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Islam A, Nakagawara, A., et al.: "High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma."Oncogene. 19. 617-623 (2000)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2001-10-23  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi